Dr Anthony Coyne

Publications

Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors.

M Sabbah, V Mendes, RG Vistal, DMG Dias, M Záhorszká, K Mikušová, J Korduláková, AG Coyne, TL Blundell, C Abell

Journal of medicinal chemistry

(2020)

4749

Using a fragment-based approach to identify novel chemical scaffolds targeting the dihydrofolate reductase (DHFR) fromMycobacterium tuberculosis

JA Ribeiro, A Hammer, GAL Zúñiga, SM Chavez-Pacheco, P Tyrakis, GS de Oliveira, T Kirkman, JE Bakali, SA Rocco, ML Sforça, R Parise-Filho, AG Coyne, TL Blundell, C Abell, MVB Dias

(2020)

(doi: 10.1101/2020.03.30.016204)

Fragment-Based Design of Mycobacterium Tuberculosis InhA Inhibitors

M Sabbah, V Mendes, RG Vistal, DMG Dias, M Záhorszká, K Mikušová, J Korduláková, A Coyne, TL Blundell, C Abell

(2020)

(doi: 10.26434/chemrxiv.10280849.v2)

Fragment-Based Design of Mycobacterium Tuberculosis InhA Inhibitors

M Sabbah, V Mendes, RG Vistal, DMG Dias, M Záhorszká, K Mikušová, J Korduláková, A Coyne, TL Blundell, C Abell

(2020)

(doi: 10.26434/chemrxiv.10280849)

InhibitingMycobacterium tuberculosisCoaBC by targeting a new allosteric site

V Mendes, SR Green, JC Evans, J Hess, M Blaszczyk, C Spry, O Bryant, J Cory-Wright, DS-H Chan, PHM Torres, Z Wang, S O’Neill, S Damerow, J Post, T Bayliss, SL Lynch, AG Coyne, PC Ray, C Abell, KY Rhee, HIM Boshoff, CE Barry, V Mizrahi, PG Wyatt, TL Blundell

(2019)

(doi: 10.1101/870154)

Allosteric Small-Molecule Serine/Threonine Kinase Inhibitors.

RC Panicker, S Chattopadhaya, AG Coyne, R Srinivasan

Advances in Experimental Medicine and Biology

(2019)

1163

253

(doi: 10.1007/978-981-13-8719-7_11)